Enhancing Treatment Strategies With Molecular Approaches in HER2+ Gastrointestinal Cancers
- Author
- ReachMD
- Published
- Thu 08 Aug 2024
- Episode Link
- http://reachmd.com/programs/cme/enhancing-treatment-strategies-with-molecular-approaches-in-her2-gastrointestinal-cancers/18134/
CME credits: 1.00
Valid until: 08-08-2025
Claim your CME credit at https://reachmd.com/programs/cme/enhancing-treatment-strategies-with-molecular-approaches-in-her2-gastrointestinal-cancers/18134/
Valid until: 08-08-2025
Claim your CME credit at https://reachmd.com/programs/cme/enhancing-treatment-strategies-with-molecular-approaches-in-her2-gastrointestinal-cancers/18134/
Join us for a CME online broadcast replay of a live satellite symposium from ESMO GI 2024, where experts discuss strategies to overcome barriers to implementing a collaborative, biomarker-based approach in precision oncology for HER2+ GI cancers. Learn how to individualize therapeutic planning and sequencing for patients with HER2+ gastric/GEJ cancers and improve response and durability in mCRC with HER2-directed therapies. The symposium also covers the role of genomic profiling in guiding treatment decisions for HER2+ BTC and emphasizes the importance of interprofessional collaboration in managing adverse events associated with HER2-directed therapies in patients with GI cancer.
=